THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA

Stroke is a leading cause of death and disability, where the main risk factor is hypertension. Angiotensin Receptor Blocker (ARB) is the most common drug for stroke prevention in high-risk hypertensive patients. The purpose of this study was to see whether the candesartan pre-stroke use can improve...

Full description

Bibliographic Details
Main Authors: Lise Insani Gulo, Rizaldy Taslim Pinzon, Esdras Ardi Pramudita
Format: Article
Language:English
Published: Universitas Sanata Dharma 2018-05-01
Series:Jurnal Farmasi Sains dan Komunitas
Subjects:
Online Access:http://e-journal.usd.ac.id/index.php/JFSK/article/view/660
_version_ 1811290921536323584
author Lise Insani Gulo
Rizaldy Taslim Pinzon
Esdras Ardi Pramudita
author_facet Lise Insani Gulo
Rizaldy Taslim Pinzon
Esdras Ardi Pramudita
author_sort Lise Insani Gulo
collection DOAJ
description Stroke is a leading cause of death and disability, where the main risk factor is hypertension. Angiotensin Receptor Blocker (ARB) is the most common drug for stroke prevention in high-risk hypertensive patients. The purpose of this study was to see whether the candesartan pre-stroke use can improve the functional outcomes of post ischemic stroke patients. The data were obtained from 191 retrospective observational studies. Data were collected from Stroke Registry and medical record at Bethesda Hospital Yogyakarta in 2014-2016, then analyzed univariate, followed by bivariate analysis using chi-square test, independent t-test and fisher exact test for the variable which has actual count (F0), and logistic regression for multivariate analysis. One hundred and ninety one samples were systematically reviewed to evaluate the effect of candesartan pre-stroke use on functional outcomes of post ischemic stroke patients in Bethesda hospital Yogyakarta whose range of ages was mostly between 61 and 70 years (30.9%) and were mostly male patients (56.5%). Patients with good functional outcomes (<2) were 79.6% and poor functional outcomes (≥2) were 20.4%. The results of bivariate analysis showed that candesartan did not affect the improvement of clinical outcome (OR: 1.806, 95% CI: 0.591-5.519, p: 0.294), and also not better than other angiotensin receptor blocker (p=0.505, OR=1.472, 95% CI= 0.470-4.611). The multivariate analysis showed that sex (OR: 0.366, 95% CI: 0.156-0.858, p: 0.021), loss of consciousness (OR: 0.107, 95% CI: 0.021-0.549, p: 0.007), limb weakness (OR: 0.236, 95% CI: 0.067-0.834, p: 0.025), dyslipidemia comorbidity (OR: 2.750, 95% CI: 1.177-6.427, p: 0.019) and aphasia (OR: 0.342, 95% CI: 0.107-1.100, p: 0.072) affected the functional outcome. The candesartan pre-stroke use did not improve the functional outcome of post ischemic stroke patient.
first_indexed 2024-04-13T04:20:41Z
format Article
id doaj.art-cb560363d9c54db79f76399f5dc94555
institution Directory Open Access Journal
issn 1693-5683
2527-7146
language English
last_indexed 2024-04-13T04:20:41Z
publishDate 2018-05-01
publisher Universitas Sanata Dharma
record_format Article
series Jurnal Farmasi Sains dan Komunitas
spelling doaj.art-cb560363d9c54db79f76399f5dc945552022-12-22T03:02:47ZengUniversitas Sanata DharmaJurnal Farmasi Sains dan Komunitas1693-56832527-71462018-05-01151374610.24071/jpsc.151660937THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTALise Insani Gulo0Rizaldy Taslim Pinzon1Esdras Ardi Pramudita2DUTA WACANA CHRISTIAN UNIVERSITYBethesda Hospital Yogyakarta, Jalan Jendral Sudirman No. 70, Kotabaru, Gondokusuman, Kota Yogyakarta, Daerah Istimewa YogyakartaPanti Rapih Hospital, Jl. Cik Di Tiro No.30, Caturtunggal, Kec. Depok, Kabupaten Sleman 55223, Daerah Istimewa YogyakartaStroke is a leading cause of death and disability, where the main risk factor is hypertension. Angiotensin Receptor Blocker (ARB) is the most common drug for stroke prevention in high-risk hypertensive patients. The purpose of this study was to see whether the candesartan pre-stroke use can improve the functional outcomes of post ischemic stroke patients. The data were obtained from 191 retrospective observational studies. Data were collected from Stroke Registry and medical record at Bethesda Hospital Yogyakarta in 2014-2016, then analyzed univariate, followed by bivariate analysis using chi-square test, independent t-test and fisher exact test for the variable which has actual count (F0), and logistic regression for multivariate analysis. One hundred and ninety one samples were systematically reviewed to evaluate the effect of candesartan pre-stroke use on functional outcomes of post ischemic stroke patients in Bethesda hospital Yogyakarta whose range of ages was mostly between 61 and 70 years (30.9%) and were mostly male patients (56.5%). Patients with good functional outcomes (<2) were 79.6% and poor functional outcomes (≥2) were 20.4%. The results of bivariate analysis showed that candesartan did not affect the improvement of clinical outcome (OR: 1.806, 95% CI: 0.591-5.519, p: 0.294), and also not better than other angiotensin receptor blocker (p=0.505, OR=1.472, 95% CI= 0.470-4.611). The multivariate analysis showed that sex (OR: 0.366, 95% CI: 0.156-0.858, p: 0.021), loss of consciousness (OR: 0.107, 95% CI: 0.021-0.549, p: 0.007), limb weakness (OR: 0.236, 95% CI: 0.067-0.834, p: 0.025), dyslipidemia comorbidity (OR: 2.750, 95% CI: 1.177-6.427, p: 0.019) and aphasia (OR: 0.342, 95% CI: 0.107-1.100, p: 0.072) affected the functional outcome. The candesartan pre-stroke use did not improve the functional outcome of post ischemic stroke patient.http://e-journal.usd.ac.id/index.php/JFSK/article/view/660angiotensin receptor blockercandesartanfunctional outcomeischemic strokeneuron protection
spellingShingle Lise Insani Gulo
Rizaldy Taslim Pinzon
Esdras Ardi Pramudita
THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
Jurnal Farmasi Sains dan Komunitas
angiotensin receptor blocker
candesartan
functional outcome
ischemic stroke
neuron protection
title THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
title_full THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
title_fullStr THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
title_full_unstemmed THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
title_short THE EFFECT OF CANDESARTAN PRE-STROKE USE ON THE FUNCTIONAL OUTCOME OF POST ISCHEMIC STROKE PATIENTS IN BETHESDA HOSPITAL YOGYAKARTA
title_sort effect of candesartan pre stroke use on the functional outcome of post ischemic stroke patients in bethesda hospital yogyakarta
topic angiotensin receptor blocker
candesartan
functional outcome
ischemic stroke
neuron protection
url http://e-journal.usd.ac.id/index.php/JFSK/article/view/660
work_keys_str_mv AT liseinsanigulo theeffectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta
AT rizaldytaslimpinzon theeffectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta
AT esdrasardipramudita theeffectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta
AT liseinsanigulo effectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta
AT rizaldytaslimpinzon effectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta
AT esdrasardipramudita effectofcandesartanprestrokeuseonthefunctionaloutcomeofpostischemicstrokepatientsinbethesdahospitalyogyakarta